U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

2.
Figure 2

Figure 2. From: Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Risk of bias summary, stressing authors’ judgments about each risk of bias item for the included RCTs.

Maria G. Grammatikopoulou, et al. Nutrients. 2018 Nov;10(11):1737.
3.
Figure 3

Figure 3. From: Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Forest plots for the attainment of remission among ulcerative colitis patients receiving curcumin vs. placebo as an adjuvant according to the intention-to-treat (a), and per protocol analyses (b). CI: confidence intervals; M-H: Mantel–Haenszel; Random: Random effects model.

Maria G. Grammatikopoulou, et al. Nutrients. 2018 Nov;10(11):1737.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center